GWPH

GW Pharmaceuticals PLC

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

GWPH price

GW Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GWPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals GWPH

Valuation

P/E

Sector 1.09

Industry -1.78

P/BV

Sector 1.86

Industry 1.35

P/Revenue (PSR)

Sector 1.55

Industry 2.25

EV/EBITDA

Sector -47.62

Industry -42.38

EV/EBIT

Sector -27.52

Industry -45.58

P/EBITDA

0.00

Sector -32.64

Industry -23.10

P/EBIT

0.00

Sector -43.02

Industry -27.18

P/Total Assets

0.00

Sector 0.87

Industry 0.82

P/Net Current Assets

Sector -27.09

Industry -72.46

P/Working Capital

Sector -4.05

Industry -2.10

EPS

-0.18

Sector -0.70

Industry -1.11

BVPS

1.95

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

0.00%

Sector 49.36%

Industry 50.48%

EBITDA Margin

-14.07%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-16.60%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

0.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

0.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.16

Sector 0.13

Industry 0.06

Profitability

ROE

Sector -24.32%

Industry -33.33%

ROA

Sector -24.41%

Industry -45.72%

ROIC

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 1.90

Industry 2.51

Net Debt / EBITDA

20.94

Sector -4.96

Industry -8.98

Net Debt / EBIT

17.76

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.61

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.01

Sector -0.74

Industry -0.56

Equity/Assets

0.79

Sector 0.46

Industry 0.52

Liabilities/Assets

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

29.67%

Sector -

Industry -

5Y Earnings CAGR

28.83%

Sector -

Industry -

Fundamentals GWPH

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
GWPH GW Pharmaceuticals PLC	$0.00	-	0.00%	0.00	0.00	0.00%	0.00%
LLY Eli Lilly and Compay	$1,142.35	51.23%	0.59%	38.16	30.09	78.84%	33.53%
SNY Sanofi	$42.38	-6.23%	4.17%	3.97	0.73	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.03	29.66%	3.54%	15.39	4.35	28.24%	14.54%
CRMD CorMedix Inc.	$7.69	-30.85%	0.00%	3.22	1.31	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.73	-12.06%	0.00%	13.18	1.35	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.16	-17.58%	0.69%	27.59	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.78	-95.06%	0.00%	0.01	0.01	63.85%	0.00%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
NVS Novartis AG	$139.78	16.35%	2.22%	20.89	6.35	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$653.75	38.92%	0.28%	34.71	4.60	13.25%	15.07%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%
HCA HCA Healthcare Inc.	$429.56	8.26%	0.70%	12.06	-29.52	-244.72%	10.07%
COHR Coherent Inc.	$308.78	198.60%	0.00%	75.62	5.36	7.09%	11.19%
DHR Danaher Corporation	$211.66	9.40%	0.68%	37.21	2.83	7.61%	15.95%
SYK Stryker Corp.	$276.81	-25.56%	1.26%	28.38	4.41	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GWPH Historical Dividends

current DY: %

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT GW Pharmaceuticals

GW Pharmaceuticals PLC

Average Investor10 user rating

4.0 (1 people)

United States

25 years

Founded: 2001

2013

Time since IPO - 13 years

1.161

Employees

GW Pharmaceuticals PLC (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $736.37 million.

The company employs approximately 1.161 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, GW Pharmaceuticals PLC reported $559.04 million in revenue, generating net income of $-69.84 million.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.

The company trades under the ticker GWPH.

Market cap

Net worth

$736.37 million

$736,373,000.00

Assets

$934.34 million

$934,343,000.00

Total Shares Outstanding

378.51 million

378,505,000

Average Daily Trading Volume

$694.46 Thousand

$694,459.96

Sector

Health

Industry

Pharmaceutical Products

GWPH

GWPH revenue and profits

Financial Results GWPH

DRAG THE FRAME TO SEE MORE DATA

GWPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35